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Abstract
Background: Caspases are a family of cysteinyl proteases that regulate apoptosis and other biological processes.
Caspase-3 is considered the central executioner member of this family with a wide range of substrates.
Identification of caspase-3 cellular targets is crucial to gain further insights into the cellular mechanisms that have
been implicated in various diseases including: cancer, neurodegenerative, and immunodeficiency diseases. To date,
over 200 caspase-3 substrates have been identified experimentally. However, many are still awaiting discovery.
Results: Here, we describe a powerful bioinformatics tool that can predict the presence of caspase-3 cleavage sites
in a given protein sequence using a Position-Specific Scoring Matrix (PSSM) approach. The present tool, which we
call CAT3, was built using 227 confirmed caspase-3 substrates that were carefully extracted from the literature.
Assessing prediction accuracy using 10 fold cross validation, our method shows AUC (area under the ROC curve) of
0.94, sensitivity of 88.83%, and specificity of 89.50%. The ability of CAT3 in predicting the precise cleavage site was
demonstrated in comparison to existing state-of-the-art tools. In contrast to other tools which were trained on
cleavage sites of various caspases as well as other similar proteases, CAT3 showed a significant decrease in the
false positive rate. This cost effective and powerful feature makes CAT3 an ideal tool for high-throughput screening
to identify novel caspase-3 substrates.
The developed tool, CAT3, was used to screen 13,066 human proteins with assigned gene ontology terms. The
analyses revealed the presence of many potential caspase-3 substrates that are not yet described. The majority of
these proteins are involved in signal transduction, regulation of cell adhesion, cytoskeleton organization, integrity
of the nucleus, and development of nerve cells.
Conclusions: CAT3 is a powerful tool that is a clear improvement over existing similar tools, especially in reducing
the false positive rate. Human proteome screening, using CAT3, indicate the presence of a large number of
possible caspase-3 substrates that exceed the anticipated figure. In addition to their involvement in various
expected functions such as cytoskeleton organization, nuclear integrity and adhesion, a large number of the
predicted substrates are remarkably associated with the development of nerve tissues.
Keywords: Apoptosis, Caspase-3, Caspase substrates, Cleavage site prediction, Position-Specific Scoring Matrix
(PSSM), Human proteome, Bioinformatic tool, Pattern recognition
Background
Caspases are a family of intracellular cysteinyl aspartate-
specific proteases that are highly conserved in multicel-
lular organisms and are key regulators of apoptosis
initiation and execution. At least 14 members of the
caspase family have been identified in mammals and
they are grouped into two major sub-families, namely
inflammatory caspases and apoptotic caspases. Apopto-
sis associated caspases can be further classified into two
groups: initiator caspases, including caspase-2, -8, and
-9, which are present upstream of apoptosis signalling
pathways; and executioner (effectors) caspases -3, -6,
and -7 [1-3].
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auto-cleavage process that is mediated by large adaptor-
caspase complexes known respectively as the death-
inducing signalling complex (DISC) and apoptosome.
These complexes are usually formed in response to an
intrinsic or extrinsic cell death stimulus [4]. The main
targets of the activated initiator caspases are the execu-
tioner procaspases. It is interesting to notice that sub-
strates of initiator caspases are limited to their own
precursors, executioner procaspases-3, -6, and -7, and
few more proteins [5]. On the other hand, executioner
caspases target a large number of cellular proteins to
control the dismantling process of the cell [6]. In addi-
tion to their essential role in apoptosis, recent accumu-
lated evidence demonstrates various non-apoptotic
functions of executioner caspases including: regulation
of the immune response, cell proliferation, differentia-
tion and motility [7,8].
Caspases are characterized by high substrate selectiv-
ity. They recognize a specific sequence signal in their
target proteins. Resolving substrate specificity for cas-
pases was initially investigated using a combinatorial
approach with positional scanning of synthetic tetrapep-
tidyl-aminomethyl coumarin derivatives. The results of
this approach determined the absolute requirements for
aspartic acid at position P1 [9,10]. In addition, P2 to P4
positions demonstrate high preference for certain amino
acids. Based on positional scanning of synthetic tetra-
peptides, the preferred recognition sequences for cas-
pases -1, -4, and -5 were determined to be (W/L)EHD,
whereas caspases -3, and -7 recognize the sequence
DEVD, while caspases- 8, -6, -9, and -10 recognize the
sequence (D/L)E(H/T)D.
It is important to emphasize that the in vitro caspase
substrate specificity, determined by the synthetic tetra-
peptide method, is not absolutely representative of the
cleavage conditions in vivo. The cleavage specificities of
caspases in vivo are influenced by sequence-dependent
conformational features, flanking the cleavage tetrapep-
tide motif, which can control the molecular electrostatic
potential and the steric accessibility of the enzyme to its
target protein. For example, and in spite of their identi-
cal preference for the DEVD tetrapeptide cleavage motif,
caspase-3 and 7 show a clear differential preference for
various natural substrates [11,12]. Demon et al [13]
demonstrated that in addition to the tetrapeptide clea-
vage core, DEVD (P4-P1), several amino acid positions
located outside this core such as P6, P5, P2’ and P3’ are
critical in the discrimination of caspase-7 and caspase-3
for their specific substrates.
Shen et al [14] reported another interesting example
which proves that the relatively similar tetrapeptide clea-
vage motif of caspase-1 and caspase-9, which are func-
tionally distinct, does not imply a similar recognition
preference for their natural substrates. Via a thorough
statistical analysis of a window size of P10-P10’ for a
collection of caspase-1 and caspase-9 natural substrates,
Shen et al have determined the significance of various
amino acids and/or certain physiochemical properties at
certain positions outside the canonical tetrapeptide
motif [14].
Among executioner caspases, caspase-3 is considered
the major enzyme with a wide array of cellular sub-
strates. While immunodepletion of caspase-3 abolishes
the majority of proteolytic events observed during apop-
tosis, immunodepletion of other executioner caspases
shows a minimal impact on apoptosis markers and its
proteolytic cleavage outcomes [11]. In the last decade,
extensive research on caspases led to the identification
of more than 200 caspase-3 substrates and the list is
still growing. With the increasing number of proteins
that have been discovered, thanks to the sequencing of
the human genome and the genomes of many other
organisms, there is a need for efficient methods that can
help in discovering new caspase-3 substrates. The iden-
tification of new cellular substrates for caspase-3 would
lead to further insights into the cellular mechanisms
that regulate apoptosis, proliferation, and other biologi-
cal processes.
Bioinformatics tools would allow high-throughput
analyses of proteomic data in order to screen for puta-
tive caspase-3 substrates. In addition, such tools can
provide researchers with an accurate map of the poten-
tial cleavage site(s) for a given sequence of interest. In
the last few years, several computer-based tools were
developed with the aim of predicting caspase substrates.
Prediction of Endopeptidase Substrates (PEPS) [15] was
among the initial tools and it was developed in order to
predict putative caspase-3, cathepsin B and cathepsin L
cleavage sites using cleavage site scoring matrices
(CSSM). PeptideCutter [16] is another tool that was
designed with the objective of predicting cleavage sites
for a wide range of proteases including various caspases.
GraBCas [17] is a tool that uses a position specific scor-
ing matrix for caspases 1-9 and granzyme B, based on
substrate specificities that were determined by positional
scanning of synthetic peptides. CaSPredictor [18] was
developed based on the assumption that sequences rich
in the amino acids Ser (S), Thr (T), Pro (P), Glu or Asp
(D/E) (collectively called PEST) are favoured caspase
cleavage sites. CaSPredictor was built based on 137
experimentally verified natural substrates for caspase-1,
-2, -3, -6, -7, -8, -9, and -10.
In addition to the previously aforementioned scoring-
matrix based approaches, several groups recently
reported the development of tools that were mainly
built up using the support vector machine (SVM) tech-
nique. Wee et al. [19] described an SVM based
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ferent caspases from various organisms. Cascleave [20]
is an interesting tool that was recently developed utiliz-
ing primary sequence, as well as secondary structure
features, of the cleaved sites based on SVM approach.
Cascleave was built using a dataset of 370 substrates of
the different caspases. Piippo et al [21] described
another tool (termed Pripper) using three different pat-
tern recognition classifiers, namely: SVM, a decision tree
based method known as J48, and the Random Forest
classifier. The three classifiers were trained on 443 dif-
ferent caspase cleavage sites. Li et al [22] proposed a
hybrid SVM-PSSM method based on an extended data-
set. Unfortunately, some of these tools are not available
for testing and comparison purposes.
Despite the substantial efforts to develop in silico sys-
tems to predict sites of caspase cleavage, the accuracy of
such tools is still a challenging issue. The major draw-
back of the early tools is the use of training datasets
that represent synthetic peptides or limited natural sub-
strates for various proteases including caspases. On the
other hand, the recently developed SVM-based tools
were built using a mixture of heterogeneous data that
represent cleavage sites of the different caspases includ-
ing non-canonical sites as well as some unverified cas-
pase substrates. In general the SVM-based tools such as
Cascleave achieve good levels of sensitivity, yet they suf-
fer from high rates of false positive results. It is gener-
ally expected that training a prediction tool on data
representing distinctive patterns can lead to overgenera-
lization and hence a high rate of false positive results. It
is important to recall that although different caspases
share the primary sequence-requirement to cleave at the
carboxyl terminal of aspartate residues in their protein
targets, each one of these proteases recognizes a unique
context surrounding the cleavage position. Even the cas-
pases that appear to have identical tetrapeptide cleavage
specificities such as caspase-3 and -7 are actually dis-
tinct in terms of the amino acids preferences outside
t h et e t r a p e p t i d ec o r es e q u e n c e[ 1 3 ] .B a s e do nt h i s
assumption, we decided to develop a prediction tool
focusing on data that represent substrates of a single
caspase. Caspase-3 was selected for this objective as it
represents the major executioner caspase with a consid-
erable number of substrates.
In this work, we present a novel tool designated Cas-
pase Analysis Tool 3 (CAT3), which was developed
based on an extensive and highly curated dataset of cas-
pase-3 substrates. CAT3 showed an obvious improve-
ment in the overall prediction accuracy as well as a
marked reduction of the false positive rate. Using CAT3,
a high-throughput screening was performed on a large
set of human proteins with assigned Gene Ontology
(GO) annotations. The screening results reveal the
existence of a large number of potential caspase-3
substrates.
Implementation
Methods
Caspase-3 substrates
The PubMed literature database [23] was used to search
for papers that describe human, mouse, and rat caspase-
3 substrates. Each paper was critically analyzed to deter-
mine the experimentally demonstrated cleavage position
in the relevant protein. The confirmed caspase-3 sub-
strates were 227 proteins with a total of 267 cleavage
sites. The amino acid sequences of the proteins were
then obtained from the Universal Protein Resource
Knowledgebase (UniProtKB) [24]. Of the 267 cleavage
sites, 17 sequences were sorted randomly to be used
later to compare the performance of CAT3 versus exist-
ing similar tools; the remaining 250 sequences, which
we refer to as the positive (+) peptide data, were used
for training and validation of the CAT3.
Definition of study controls
The following datasets were established as controls in
this study:
The negative uncleaved peptides This data set consists
of all the peptides that contain aspartic acid residues
and are presumed to be uncleaved. This control group
was established based on the assumption that any D
residue, in a caspase-3 substrate, apart from the mapped
cleavage site(s) is most likely uncleaved. After excluding
the positive peptides that exist in training data, the
remaining 8968 D residues were used to create this
negative (-) control.
Amino acids natural frequency This control represents
the frequency of each one of the 20 amino acids in a
group of 20,224 human proteins that were available as
reviewed proteins in the UniProtKB [24] as of March
2011.
Amino acid R-groups frequency This control repre-
sents the frequencies of the different R-groups of amino
acids; acidic (D and E), basic (H, K and R), polar (N, Q,
S, T and Y), and non-polar (A, L, P, M, G, V, I, F, W
and C). The frequencies were calculated based on the
above mentioned 20,224 reviewed proteins.
Physiochemical characteristics flanking the cleavage site
The positive peptide sequences were aligned in refer-
ence to the cleaved aspartic acid residues. The resulting
multiple sequence alignment was divided into three
regions: the central tetrapeptide cleavage motif
(P4P3P2P1), the N-terminal region preceding the motif
and the C-terminal region following the motif that was
designated “before-motif” and “after-motif”, respectively.
The analyses for the regions flanking the motif were
made serially: 50, 30, 20, 10, and 5 amino acids before
and after the motif (Figure 1). The analysis included: the
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groups (acidic, basic, polar and non-polar), the frequen-
cies of hydrophobic and hydrophilic amino acids and
finally the frequencies for each single amino acid. In the
case of tetrapeptide motif analysis, the different frequen-
cies were calculated separately for each position: P4, P3,
P2 and P1. However, the frequencies within 50, 30, 20,
10, and 5 amino acids, before and after the motif, were
calculated collectively for each region.
Establishment of scoring matrices
The peptides that fulfil the length criterion, P9-P5’,
which means having 8 amino acids before and 5 amino
acids after the aspartate residue of interest, were used to
build the scoring matrices. Both the positive and the
negative peptide data sets were used to build the scoring
matrices. The first step was to generate position specific
frequency matrices from the multiple sequence align-
ments of the relevant set of peptides. Each matrix con-
sisted of 14 rows, representing positions P9P8P7P6P5
P4 P3 P2 P1P1’ P2’ P3’P4’P5’, where a D amino acid is
at the position P1. The 20 columns of the matrix repre-
sent the frequencies of each amino acid.
From the multiple sequence alignment of the positive
peptides, we noticed the presence of two possibly differ-
ent patterns; the first pattern has a D at P4 (P9...P5-D-
X-X-D...P5’) and the second has any amino acid except
D at P4 (P9...P5-X-{D}-X-X-D...P5’). To represent this
subtle difference, we decided to construct amino acid
frequency matrices to represent each sub-pattern.
Two weighting systems were used in order to correct
the probability of overrepresented and underrepresented
amino acids in the frequency matrices so as to establish
the scoring matrices:
i) Calculating log odd ratio: This weighting system
involves calculating log odd ratio for each element in
the frequency matrix by dividing the observed frequency
of a given amino acid over its corresponding natural fre-
quency (see the definition of study controls above).
ii) Subtraction of negative control background: Instead
of relying only on the common log odd weighting sys-
tem and in order to minimize scoring bias, we decided
to add a second normalization approach. The method
relies on comparing the positive peptides with the nega-
tive peptides to further remove the noise signals around
the cleaved aspartate residues.
Four scoring matrices are involved in the overall calcula-
tion of the final score of CAT3 tool. We propose the fol-
lowing notation to define each scoring matrix and the
overall score. First, let FM1
+ denote the frequency matrix
that was constructed from all the positive (+) peptides.
The corresponding scoring matrix ’A’ is defined as:
A =l o g 2
FM1+
 (1)
where Ω is the natural frequencies of the amino acids.
In addition to the above scoring matrix we define FM1
-
as the frequency matrix generated from the negative (-)
peptides. A new frequency matrix ’B’ is defined as:
B =l o g 2
FM1+−FM1−
 (2)
Let FM
[·]
c denote a frequency matrix calculated from a
subset of peptides that fulfil the constraint ’c’. Here, [·]
is either + or - as explained before.
Therefore, we define the following scoring matrices:
C1 =l o g 2

FM1+
P4=D

−

FM1−
P4=D


(3)
and
C2=l o g 2

FM1+
P4 =D

−

FM1−
P4 =D


(4)
CAT3 implementation and scoring
CAT3 tool was built using Perl language. The input pro-
tein can be entered either as a FASTA format sequence
6WHSDD0DD  
6WHSDD0DD  
6WHSDD0DD  
6WHSDD0DD  
6WHSDD0DD  
$QDO\]HGUHJLRQV
7HWUDSHSWLGHPRWLIµ0¶
1WHUPLQDO &WHUPLQDO
3333
3333
3333
3333
3333
Figure 1 Sequence analyses. This drawing shows the regions surrounding the tetra-peptide motif (P4P3P2P1) that were included in the
physiochemical analyses. In each step, a given length of amino acids (bold dashed lines) at both N- and C- directions were analyzed.
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P1 is identified, it is analyzed to calculate the final score
’S’ as follows:
S =
a+b+c
3
(5)
where ’a’ and ’b’ are scores generated from the scor-
ing matrices ’A’ and ’B’ in Equation 1 and Equation 2,
respectively. The ’c’ score is generated either from the
scoring matrix ’C1’or ’C2’ as follows:
c =

C1 if P4 = D
C2 if P4  =D
(6)
We refer to the scoring matrix ’C1’ if the peptide con-
tains the amino acid D at P4 or the scoring matrix ’C2’
if the amino acid at P4 is not D. The three scores (a, b,
and c) are normalized to a 100% score by dividing each
s c o r eb yt h em a x i m u ms c o r et h a tc o u l db eo b t a i n e d
from each formula.
CAT3 validation
To examine the prediction power of CAT3 a k = 10 fold
cross validation was performed. The positive data were
the actual cleavage sites, whereas the negative data were
obtained from the uncleaved dataset. In each fold four
PSSM matrices were created from 9/10th of the positive
substrates. Then, the remaining 1/10th positive and
negative substrates are used for testing. Since the num-
ber of the negative peptides was much larger than the
positive peptides, an equal number of the negative pep-
tides were randomly obtained. The whole 10 fold cross
validation experiment was repeated 10 times to ensure a
good coverage of the negative dataset. The sensitivity
(SEN), specificity (SPE), positive predictive value (PPV),
negative predictive value (NPV), accuracy (ACC) and
the Matthew’s correlation coefficient (MCC) were calcu-
lated as in [25].
The areas under the receiver operating characteristic
(ROC) curves were calculated by plotting the sensitivity
against the corresponding 1-specificity. The optimal cut-
off point was defined as that measurement that corre-
sponded to the point on the ROC curve closest to the
top left corner, i.e., closest to having sensitivity = 1 and
specificity = 1.
Local window size
The most appropriate local window size of amino acid
sequence encompassing the cleaved aspartate and other
critical exosite residues was determined based on com-
paring the prediction performance of the following pep-
tides: P3-P1, P4-P1, P5-P1’,P 6 - P 2 ’,P 7 - P 3 ’,P 8 - P 4 ’,P 9 -
P5’,P 1 1 - P 7 ’, P14-P10’, P17-P13’, P20-P16’, P23-P19’.
The performance of each window size was evaluated
using the same cross validation approach as mentioned
above. The obtained area under curve (AUC) and Mat-
thew’s correlation coefficient (MCC) for the different
experiments were plotted for comparison purposes.
Performance comparison
A performance comparison was carried out for CAT3
versus two recently published prediction tools, namely
CASVM and Cascleave [19,20]. The aim of the test was
to assess how accurate the three tools were in predicting
caspase-3 cleavage sites. The comparison was made on
16 caspase-3 substrates that were randomly excluded
from the training dataset.
Since CAT3 is a prediction tool specific for caspase-3
cleavage sites, whereas CASVM and Cascleave were
developed to predict cleavage sites of different caspases,
there is a possibility to misjudge true positive sites of
other caspases by assigning them to the false positive
category of CASVM and Cascleave. To avoid such
unfair comparison, the 16 substrates were carefully
inspected to find all caspase cleavage sites. The search
was performed using the PubMed database, Google
searching engine, the Caspase Substrate database Home-
page (CASBAH) [26], and MERPOS - the Peptidases
Database [27].
The protein sequences of the 16 substrates were ana-
lyzed individually and the prediction results for each
tool were counted according to software default para-
meters. The true positives are the positively predicted
caspase-3 cleavage sites, whereas the false positives are
the positively predicted aspartates that are actually not
recognized by any caspase.
High-throughput screening
The UniProtKB [24] was used to retrieve human pro-
teins with known biological processes. Two filters of the
advance search option were used: the first was organism:
Homo sapiens (Uniprot ID: 9606) and the second was
Gene Ontology GO: biological process (GO ID:
0008150). After excluding the experimentally verified
215 human caspase-3 substrates, a total of 13066
reviewed human proteins with defined Gene Ontology
(biological process) were obtained. The protein
sequences were analyzed by CAT3 to screen for poten-
tial novel caspase-3 substrates. Only results of scores ≥
45 were considered for further analyses. Proteins that
were predicted as potential caspase-3 substrates were
further analyzed using ToppGene Suite tool [28] to
retrieve the most significant Gene Ontology (GO) terms.
Results
Caspase 3 substrates
Our search in the PubMed literature database for cas-
pase-3 substrates revealed the presence of 227 proteins:
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origin. All the substrates were experimentally verified as
natural substrates and their cleavage sites were mapped.
Of the 227 substrates, the cleavage sites of 189 proteins
were mapped by site-directed mutagenesis technique,
while the remaining 38 were mapped by different high-
throughput proteomic screening approaches. The full
list and description of the obtained substrates are avail-
able in the additional materials (Additional file 1). The
obtained caspase-3 substrates as well as other caspase
substrates will be available in the Caspase Substrates
Comprehensive Database (CaspoSome Database) that
has been developed at our institute (unpublished
results).
Tetrapeptide cleavage motif analysis
The tetrapeptide cleavage motifs (P4P3P2P1) of the
training group were analyzed to determine physiochem-
ical properties and frequencies of amino acids at each
position. The examination of amino acid frequencies
within the tetrapeptide motif revealed a unique distribu-
tion pattern of hydrophobica n dh y d r o p h i l i ca m i n o
acids (Figure 2.A). Hydrophilic amino acids are 8.6
times more frequent in P4 than hydrophobic amino
acids. Interestingly, P3 has an opposite pattern to P2. In
P3 hydrophilic amino acids are nearly two times more
frequent than hydrophobic amino acids, whereas in P2
the converse is true.
Figure 2.B shows the results of analyzing the frequen-
cies of acidic, basic, polar and non-polar amino acids. In
addition to the obvious difference in amino acid group
distribution between the four positions and the corre-
sponding control, it is important to notice the lack of
basic amino acids in P4 and the high frequency of acidic
amino acids in P3 compared to the control.
Features surrounding the cleavage site
The amino acid sequences surrounding the tetrapeptide
cleavage motifs were thoroughly analyzed to identify
necessary feature(s) for caspase-3 recognition. The ana-
lyses include: secondary structure, amino acids physico-
chemical properties and amino acid composition.
The secondary structure prediction method GOR4
[29] was used to investigate the cleavage motif and its
flanking regions for any common secondary structure(s).
The analysis of GOR4 results showed that the majority
(80%) of the cleaved sites are located within unstruc-
tured context, while 18% are located within alpha helical
regions, and only 2% are located in beta sheets.
We then analyzed the biochemical properties of amino
acids that flank the tetrapeptide cleavage motif to deter-
mine amino acids preferences for caspase-3 substrate
recognition. No significant differences in the frequencies
of acidic, basic, polar and non-polar amino acids
between the tested region and the corresponding control
group were found when examining 50, 30, 20, and 10
amino acids before and after the tetrapeptide cleavage
motif. When testing the region of 5 amino acids before
the cleavage motif a slightly higher percentage of acidic
amino acids were noticed, while basic and polar amino
acids were strongly unfavoured. In the region of 5
amino acids after the cleavage motif, lower percentages
of acidic and basic amino acids were noticed (data not
shown).
To further explore the characteristic biochemical
properties, we examined individual amino acid frequen-
cies for the entire cleavage vicinity: the 5-amino acids
before and after the tetrapeptide motif. As shown in Fig-
ure 3, the frequencies of glycine, alanine, serine and pro-
line have altered distributions in regions before and after
the tetrapeptide motif that may indicate size and charge
requirements for caspase-3 recognition and binding to
the substrates.
Position specific scoring matrices
In order to determine the most appropriate window size
to construct efficient scoring matrices for CAT3, a series
of gradually increasing window sizes ranging from P3-P1
to P23-P19’ were evaluated (Figure 4). As can be seen, it
is obvious that window sizes equal to or shorter than
the tetrapeptide cleavage motif (P4-P1) are not adequate
to develop a reliable prediction tool. Despite of a mar-
ginally higher MCC at the window size of P6-P2’,t h e
overall prediction efficiency of the window sizes ranging
from P5-P1’ to P9-P5’ are apparently quite similar.
However, the efficiency seems to decrease gradually
when extending the window size beyond P9-P5’.
We actually preferred the window size P9-P5’ over
other seemingly comparable shorter alternatives for sev-
eral reasons. First, the critical analysis of amino acids
over-/under-representation scores demonstrated the sig-
nificance of all the positions in this extended window
P9-P5’ (Additional file 2). Second, a careful analysis of
natural caspase substrates, available in MEROPS data-
base, with cleavage positions near to N- or C- terminals,
indicates that minimal adequate N- and C- terminal
spacers comparable to the length of P9 and P5’,r e s p e c -
tively, are required for efficient recognition. Therefore,
our scoring matrices were developed by calculating the
weight of each amino acid in the 14-mer peptide
sequence from P9 to P5’.
To evaluate the contribution of the different amino
acids at the positions surrounding the cleaved aspartate,
the scoring matrix ’A’ (see Equation 1 in methods sec-
tion) was drawn as a heat-map (Additional file 2). Ana-
lyzing the heat-map shows that apart from the
tetrapeptide cleavage motif, all positions have either
overrepresented or underrepresented amino acids.
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and P5’ have a remarkable rejection or preference for
certain amino acids.
Prediction power of CAT3
A 10 fold cross validation was used to evaluate the pre-
dictive power of CAT3. Figure 5 shows the ROC curve
that represents the average of 10 different experiments
of the 10-fold cross validation. The optimal cut-off score
was found to be 30. At this cut-off point the prediction
statistical measures are shown in Table 1.
To demonstrate specificity of CAT3 for caspase-3
cleavage sites, a group of 25 non-caspase-3 substrates
were examined by CAT3. The substrates included 17,
12 and 5 cleavage sites of caspase-1, caspase-8 and cas-
pase-9, respectively. We avoided using any cleavage site
that was known to be a shared target with caspase-3.
Interestingly, 33 of the 34 cleavage sites (97%) showed
CAT3 scores below 30, which is the minimum cut-off
for predicting a caspase-3 cleavage site. This result pro-
vides a clear evidence to substantiate the very high spe-
cificity of CAT3 for predicting caspase-3 substrates. The
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Page 7 of 14detailed results of this experiment are available in the
additional materials (Additional file 3).
Evaluating the performance of different binary classi-
fiers is frequently made by comparing their reported sta-
tistical measures such as specificity, sensitivity etc. which
are usually calculated under different conditions. We
have avoided the use of such a comparison as it can
lead to a biased conclusion. Instead, we compared the
performance of CAT3 versus two recently reported
tools, namely CASVM and Cascleave, on a group of 16
caspase-3 substrates that were initially excluded from
our training data. It is worth mentioning that some of
these substrates could have been used in the training of
the other tools, which could offer unfair advantage to
the other two tools versus CAT3. A thorough examina-
tion using different databas e sr e v e a l e dt h a tt h e1 6s u b -
strates contain a total of 537 aspartate residues, of
which 17 are caspase-3 cleavage sites, 4 are cleavage
sites of other caspases and 516 aspartate residues that
are evidently not cleaved by any caspase.
Out of the 17 actual caspase-3 cleavage sites, the pre-
dicted true positive results for the three tools were as fol-
lows: CAT3 14/17 (82.3%), CASVM 8/17 (47%), and
Cascleave 16/17 (94.1%). However, CAT3 was the best
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Figure 3 Amino acid frequencies around the cleavage motif. The overall frequency of each amino acid was calculated for the two regions:
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to the normal frequency of each amino acid (white bars). Frequencies were obtained as described in the definition of study controls in the
Methods’ section.
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Page 8 of 14tool in reducing the false positive results (false alarm); out
of 516 actual uncleaved aspartic acid containing peptide,
CAT3 predicted only 9 false positives (1.7%), while
CASVM predicted 35 false positive (6.8%) and Cascleave
had 62 (12%) false positives. Figure 6 shows the result of
comparing CAT3 versus CASVM and Cascleave. It is
noteworthy that both CASVM and Cascleave correctly
predicted two of the 4 non-caspase-3 cleavage sites. The
detailed results of the comparison are available in the
additional materials (Additional file 4).
High-throughput screening for novel caspase-3 substrates
Screening of 13066 reviewed human proteins with
ascribed Gene Ontology (biological process) using our
CAT3 tool showed that 3320 proteins are predicted to
be caspase-3 substrates with a total of 4903 potential
caspase-3 cleavage sites (Additional file 5). To further
investigate the function of these potential substrates we
used ToppFun: an annotations based gene list functional
enrichment analysis tool [28]. Out of the 3320 genes
only 3013 had annotations in ToppFun. The analysis
revealed a group of 308 biological processes that showed
significant enrichment in predicted proteins versus the
whole human genome as a control (Additional file 6
and Additional file 7). A careful analysis of these biolo-
gical processes was performed to shortlist the most sig-
nificant biological processes by excluding general roots
(parents) and detailed leaves (children) of GO terms.
The most significant biological processes are shown in
Table 2.
ToppFun was also used to examine the enriched cellular
component GO terms. Interestingly, the majority of the
predicted proteins are located in different nuclear com-
ponents, cytoskeleton, cell projection, membrane frac-
tion, cell junction, and extracellular matrix, where most
typical apoptotic morphological and biochemical
changes are observed. The detailed list of the enriched
cellular component GO terms is available in the addi-
tional materials (Additional file 8).
Discussion
In addition to its well known key function in apoptosis,
caspase-3 has been shown to play a crucial role in the
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Figure 5 ROC curve. Receiver operating characteristic curve (ROC) for CAT3. The curve represents the average of 10 different experiments of the 10-
fold cross validation. The X-axis shows the false positive rate, while the Y-axis shows the true positive rate. The asterisk indicates the cut-off point.
Table 1 Cross validation results
Measure AUC SPE SEN PPV NPV ACC MCC
Value 0.9499 0.8850 0.8883 0.8858 0.8886 0.8866 0.7738
The values of the statistical measures represent the average of 10 different
experiments of the 10 fold cross validation test. The optimal cut-off score was
found to be 30. AUC: Area Under ROC Curve; SPE: Specificity; SEN: Sensitivity;
PPV: Positive Predictive Value; NPV: Negative Predictive Value; ACC: Accuracy;
MCC: Matthew’s correlation coefficient.
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Page 9 of 14regulation of various biological processes such as cell
differentiation, adhesion, neurodevelopment and neuro-
nal signalling [30-32]. Recognition of caspase-3 sub-
strates is becoming a vital need to understand molecular
mechanisms behind many disorders including cancer,
autoimmune and neurodegenerative diseases. Currently,
most of the known caspase-3 substrates have been iden-
tified using in vitro proteolytic cleavage assays, coupled
with site-directed mutagenesis to determine the exact
cleavage position. In recognition of the physiological
importance of caspase-3, many labs began to perform
high-throughput proteomic screening to identify novel
substrates of this major caspase [33-36]. Such techni-
ques are relatively expensive and cumbersome. In addi-
tion to the high cost, the number of identified
substrates is usually limited to the proteins that are rela-
tively abundant in the examined cell type.
Recently, several computer-based prediction tools such
as CASVM, Cascleave, and Pripper were developed in
order to help discover novel caspase substrates [19-21].
These tools were trained on data that represent sub-
strates of different caspases and in some cases non-cas-
pase endopeptidase. Although different caspases share a
primary sequence-requirement, to cleave at the carboxyl
terminal of aspartate residues in their protein targets,
each one of these proteases needs a special context
surrounding the cleavage position. Even the caspases
that appear to have identical tetrapeptide cleavage speci-
ficities such as caspase-3 and -7 are actually distinct in
terms of the amino acids preferences outside the tetra-
peptide core sequence [13]. Therefore, we believe that
building a single algorithm for predicting the cleavage of
multi-caspases would likely have low prediction specifi-
city. Based on this hypothesis, we decided to develop an
algorithm focusing only on substrates of caspase-3,
which is the major executioner caspase with a consider-
able number of targets. Our caspase-3-specific approach
(CAT3) has indeed outperformed other multi-caspases
prediction tools on an independent comparison-dataset
(Figure 6).
CAT3 has three distinctive features. Firstly, it was
developed using PSSM instead of other relatively com-
plex approaches. PSSM is known to be practical, require
low computation power and is able to represent the sta-
tistical weights of amino acids at each position. In addi-
tion, it can be easily combined with other machine
learning tools to generate hybrid approaches that might
enhance the prediction performance.
Secondly, instead of using data for different caspases,
which are actually a mixture of heterogeneous patterns,
we used an extended set of highly-curated caspase-3
natural substrates. We believe that inclusion of data that
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Page 10 of 14represents other proteases or cleavage sites of caspases
with very few substrates and/or cleavage positions repre-
senting non-canonical patterns can lead to overgenerali-
zation. In this situation, the classification model is
required to loosen its decision boundary to increase sen-
sitivity, but at the cost of having more false positive
results. It is therefore generally accepted that improve-
ment in prediction accuracy is more likely to be asso-
ciated with the good quality of the used data rather than
the complexity of the classification method. CAT3,
indeed, showed a very low rate of false positive results
in comparison to existing state-of-the-art tools, namely,
CASVM and Cascleave.
Thirdly, CAT3 is a straightforward sequence-based
scoring system that offers an easy to use reference scale
to determine the potential cleavage site(s) instead of
offering a yes-no answer or providing many suggested
cleavage sites without any score to rank them. In con-
trast to other tools that can execute a single sequence
per query, CAT3 is a fast system that can process both
s i n g l ea n dm u l t i p l es e q u e n c ei n p u t s :af e a t u r et h a t
would assist biologists to perform large scale in silico
screening to identify novel caspase-3 substrates.
Our secondary structure analyses of caspase-3 sub-
strates showed that regardless of cleavage patterns,
aspartic acid residues are predominantly located in
unstructured regions and to a lesser extent within
alpha-helices. In addition, we found the amino acids D,
E, A, G and S appear more frequently in natively
unstructured regions no matter whether they lie within
or outside cleavage motifs. These findings are in agree-
ment with various reports that used statistical analysis
to determine the natural distribution of these amino
acids and their influence on secondary structure [37-39].
This interesting result raises a question about the bene-
fit of using local secondary structure properties of the
cleavage sites as additional features to enhance the dis-
crimination between cleaved and noncleaved patterns
[20].
Careful evaluation of amino acid preference, at the
positions surrounding the tetrapeptide cleavage motif,
points to a general trend where the unfavourable amino
acids have greater weight than the favoured ones, espe-
cially at P7, P6, P1’,P 3 ’,P 4 ’,a n dP 5 ’ (Additional file 2).
Nevertheless, P1’ has a remarkable preference for speci-
fic amino acids, namely glycine and serine. In addition
to their role in determining the molecular electrostatic
potential and the steric accessibility of the enzyme, the
post-translational modification potential of these two
amino acids is vital for determining the timing and
functional consequences of cleavage. Tözsér et al. [40]
demonstrated that phosphorylation of serine residues in
close proximity to the tetrapeptide cleavage core can
determine caspase-3 cleavability. On the other hand, the
high preference for glycine at P1’ can be crucial to the
acquisition of a myristic acid at this residue.
Table 2 Significantly enriched GO terms
GO ID GO Term P-
value
Term in predicted
proteins
Term in human
genome
GO:0007155 cell adhesion 1.02E-
39
322 885
GO:0022008 neurogenesis 3.97E-
27
324 1016
GO:0007049 cell cycle 2.71E-
26
376 1250
GO:0030030 cell projection organization 6.53E-
26
263 776
GO:0009966 regulation of signal transduction 6.37E-
23
399 1399
GO:0007010 cytoskeleton organization 9.69E-
21
217 641
GO:0051276 chromosome organization 8.07E-
20
212 630
GO:0000902 cell morphogenesis 1.35E-
19
228 698
GO:0040011 locomotion 4.84E-
18
310 1071
GO:0045934 negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid
metabolic process
6.98E-
16
227 737
GO:0009790 embryo development 9.49E-
15
245 830
The GO terms of the listed biological processes were manually filtered, to reduce redundancy, by removing general roots (parents) and detailed leaves (children)
of the enriched GO terms that were obtained by ToppFun tool. The P-value of each GO term in the predicted caspase-3 proteins was derived by random
sampling of the whole genome.
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Page 11 of 14Myristoylation is a co-translational reaction that occurs
after the removal of the initiator methionine residue. It
can also occur as a post-translational modification when
internal glycine residues become exposed after caspase
cleavage. The addition of a myristate moiety can alter
subcellular localization of the cleaved proteins by facili-
tating their attachment to membranes and other pro-
teins [41].
By using CAT3, we carried out a large scale proteomic
screen to identify novel potential caspase-3 substrates.
The initial screening showed that 3320 human proteins
can be potential caspase-3 substrates. Even after normal-
izing this result by excluding the noise coming from the
presumed false positive rate, the percentage of potential
caspase-3 substrates in the human proteome would be
r o u g h l y~ 1 4 % .T h i sm e a n st h a to n l yas m a l lf r a c t i o n
(less than ~10%) of caspase-3 substrates has so far been
discovered.
The results of GO term enrichment analysis using
ToppFun showed that the majority of the predicted cas-
pase-3 substrates are involved in cell adhesion, signal
transduction, cell cycle, cytoskeleton organization, chro-
mosome organization, neurogenesis, embryo develop-
ment, cell morphogenesis, DNA metabolism (Table 2).
It is interesting to note the direct association of some of
these processes to the biochemical events that lead to
characteristic morphological changes in an apoptotic
cell. These changes include the breakup of the nuclear
envelope and actin filaments in the cytoskeleton, bleb-
bing of the plasma membrane, cell shrinkage, nuclear
fragmentation, chromatin condensation, and chromoso-
mal DNA fragmentation [42,43].
It is interesting to notice the remarkable presentation
of some biological processes that are not related to
apoptosis such as cell development and neurogenesis.
The careful analysis of the enriched biological processes
GO terms demonstrates a possible significant role of
caspases-3 in the development and differentiation of
nerve cells. In fact, several reports have shown a strong
expression of non-apoptotic active caspase-3 in various
proliferating and differentiating neuronal cells [44,45].
Further investigation focusing on the role of caspases in
nerve tissue may reveal new pathways that are necessary
for the development and differentiation of nerve cells.
The results of enriched cellular component GO terms
showed that most of the predicted substrates are distrib-
uted to nuclear components (nucleoplasm, nucleolus,
chromosome, and nuclear envelope), cytoplasmic com-
ponents (cytoskeleton and cell projection), and plasma
membrane part (cell projection and membrane fraction).
This distribution is correlated with the normal subcellu-
lar localization of caspase-3. Although the procaspase-3
is localized in the cytoplasm, active caspase-3 plays
essential roles both in the cytoplasm and nucleus [46].
Feng et al. [47] have shown that the activated caspase-3
is first observed close to the inside surface of the cellu-
lar membrane, then transferred to the cytoplasm, and
finally translocated to the nucleus.
An interesting fraction of the predicted caspase-3 sub-
strates are proteins of the extracellular matrix. The clea-
vage of such proteins can be achieved through their
cytoplasmic embedded domains. Further investigations
are needed to shed light on the biological importance of
extracellular matrix proteins and their association with
apoptotic and non-apoptotic roles of caspases.
Conclusions
In this work, we introduce a significant improvement to
the in silico prediction approach of caspase substrates.
Based on our results and in order to increase prediction
specificity, we suggest the caspase-specific approach
instead of that based upon considering the different cas-
pases’ substrates as having one common pattern. CAT3
can be considered a prototype system that would be
easily utilized in developing prediction tools for other
caspases and endopeptidases. The predicted cellular tar-
gets of CAT3 might be used to explore new pathways to
gain further insight into the cellular mechanisms that
regulate apoptosis, proliferation, and other biological
processes. In addition, the discovery of such targets
might have significant implications for the development
of drugs for various diseases including cancer, autoim-
mune disorders and neurodegenerative pathologies.
Availability and requirements
Project name: CAT3
Operating system(s): Windows
Programming language: Perl
Other requirements: none
Any restrictions to use by non-academics: none
Note: CAT-3 v 1.0 software that can process both sin-
gle and multiple sequences is provided in the additional
materials (Additional file 9).
Additional material
Additional file 1: Full list of caspase-3 substrates. This table shows
the description of the obtained 227 caspase-3 substrates. The cleavage
evidence refers to the experimental method through which cleavage
was identified. SDM stands for site directed mutagenesis, while
proteomics refers to experiments of high-throughput proteomic
screening.
Additional file 2: Heat-map representing caspase-3 cleavage
pattern. This heat-map represents the scores of the 20 amino acids in
the scoring matrix ‘A’ (see establishment of scoring matrices in the
Methods’ section). The colour intensities reflect the magnitude of amino
acid scores. The blue scale denotes the positive scores, while the yellow
to red scale denotes the negative values.
Additional file 3: Prediction results of non-caspase-3 substrates. The
three Excel sheets show the prediction results for 25 non-caspase-3
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Page 12 of 14substrates (17 cleavage sites for caspase-1, 12 cleavage sites for caspase-8
and 5 cleavage sites for caspase-9). The Pub Med ID reference and the
CAT3 score for each cleavage site are shown.
Additional file 4: Detailed results of the performance comparison.
This table shows the prediction results of CAT3 versus CASVM and
Cascleave for 16 caspase substrates (17 cleavage sites) that were not
originally included in the training of CAT3. The cleavage position(s) in all
these substrates were confirmed by site directed mutagenesis.
Additional file 5: List of predicted potential human caspase-3
substrates. This table shows the list of 3320 human proteins that were
predicted to be caspase-3 substrates. Several proteins have more than
one predicted site leading to a total of 4903 potential cleavage sites.
Only cleavage sites of scores ≥ 45 are shown.
Additional file 6: List of the significantly enriched biological process
GO terms. This table shows the full list of the significantly enriched
terms of GO: Biological Process among the 3013 predicted caspase-3
substrates.
Additional file 7: Chart representing biological processes among
predicted substrates. This figure shows the graphical representation of
the enriched GO terms: Biological Process among the 3013 predicted
caspase-3 substrates. The red bars indicate the gene count (Y-axis) per
each GO term: Biological Process (X-axis). The blue dotted line shows the
p-value for each GO term that was derived by random sampling from
the whole genome analysis.
Additional file 8: List of the significantly enriched cellular
component GO terms. This table shows the full list of the significantly
enriched terms of GO: Cellular Component among the 3013 predicted
caspase-3 substrates.
Additional file 9: Installation files for CAT-3 tool. This compressed
folder contains a total of 6 files: final_CAT3.exe, process.exe, algmodule.
pm, and submodules.pm that are needed for CAT3 software to work on
Windows operating system. The two files: Single_sequence-test.txt and
Multiple_sequences-test.txt are provided for testing purposes. To install
CAT-3 v1.0 on your PC, copy the 6 files to one folder and thereafter you
can simply start working by clicking on the CAT3.exe file.
List of abbreviations
PSSM: Position Specific Scoring Matrix; AUC: Area Under Curve; ROC:
Receiver Operating Characteristic; SVM: Support Vector Machine; UniProtKB:
Universal Protein Resource Knowledgebase; GO: Gene Ontology; SEN:
Sensitivity; SPE: Specificity; PPV: Positive Predictive Value; NPV: Negative
Predictive Value; ACC: Accuracy; MCC: Matthew’s Correlation Coefficient
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